TIAA CREF INVESTMENT MANAGEMENT LLC - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 98 filers reported holding FLEXION THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$1,052,000
+11.3%
84,284
+1.0%
0.00%0.0%
Q4 2018$945,000
-70.3%
83,447
-51.0%
0.00%0.0%
Q3 2018$3,184,000
+36.2%
170,140
+88.1%
0.00%
-50.0%
Q2 2018$2,338,000
+14.4%
90,463
-0.8%
0.00%
+100.0%
Q1 2018$2,044,000
-14.5%
91,198
-4.4%
0.00%
-50.0%
Q4 2017$2,390,000
+34.8%
95,440
+30.1%
0.00%
+100.0%
Q3 2017$1,773,000
+17.9%
73,339
-1.4%
0.00%0.0%
Q2 2017$1,504,000
-31.9%
74,402
-9.3%
0.00%
-50.0%
Q1 2017$2,207,000
+38.3%
82,028
-2.2%
0.00%
+100.0%
Q4 2016$1,596,000
+7.5%
83,891
+10.4%
0.00%0.0%
Q3 2016$1,485,000
+61.1%
75,985
+23.3%
0.00%0.0%
Q2 2016$922,000
+118.5%
61,619
+34.2%
0.00%
Q1 2016$422,000
-52.3%
45,8990.0%0.00%
-100.0%
Q4 2015$884,000
+29.6%
45,8990.0%0.00%0.0%
Q3 2015$682,000
+0.9%
45,899
+48.6%
0.00%
Q2 2015$676,000
+56.1%
30,895
+60.6%
0.00%
Q1 2015$433,000
+11.6%
19,2330.0%0.00%
Q4 2014$388,000
+9.6%
19,233
-0.8%
0.00%
Q3 2014$354,000
+35.6%
19,3910.0%0.00%
Q2 2014$261,000
+105.5%
19,391
+150.2%
0.00%
Q1 2014$127,0007,7500.00%
Other shareholders
FLEXION THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,842,578$40,001,0007.32%
MILLER VALUE PARTNERS, LLC 5,274,439$54,907,0001.97%
Mesirow Financial Investment Management, Inc. 32,371$337,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,068,580$11,124,0001.25%
Clearline Capital LP 399,159$4,155,0001.09%
CLOUGH CAPITAL PARTNERS L P 1,246,150$12,972,0000.93%
Novo Holdings A/S 1,403,370$14,609,0000.72%
SNOW CAPITAL MANAGEMENT LP 303,265$3,157,0000.63%
AMERICAN FINANCIAL GROUP INC 317,700$3,308,0000.46%
Granahan Investment Management 1,257,690$13,093,0000.44%
View complete list of FLEXION THERAPEUTICS INC shareholders